Browse COVID-19 Content


For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

Jan 7, 2021


Supply chain resilience is essential to assure consumer healthcare products Americans depend on remain widely available, including in times of disease outbreaks or global crises.

Dec 23, 2020

Press Releases and Statements

When used appropriately melatonin can play an important role in personal healthcare, but inappropriate use of supplements could be harmful. Consumers should be wary of dietary supplement products making unsubstantiated claims regarding the prevention and treatment of COVID-19.

Nov 12, 2020


Despite the challenges of COVID-19 in 2020, CHPA remained hard at work on behalf of its members.

Nov 5, 2020

Press Releases and Statements

CHPA released the following statement in response to ongoing efforts by the U.S. Food and Drug Administration (FDA) to keep hand sanitizers that contain harmful substances off the market.

Aug 13, 2020

Press Releases and Statements

The Consumer Healthcare Products Association released the following statement in response to the Trump Administration’s “Buy American” Executive Order (EO) for essential pharmaceuticals.

Aug 6, 2020


More than nine in ten Americans feel anxious about their finances amid the COVID-19 pandemic. Healthcare bills were noted as one of the top ten stressors.

Jul 31, 2020

Press Releases and Statements

The results of nearly all recent observational studies of patients from around the world diagnosed with COVID-19 show no association between exposure to NSAIDs (including ibuprofen) and worsening clinical outcomes.

Jun 23, 2020


What follows is a timeline for implementation of OTC monograph reform under HR 748, also known as the CARES Act.

Jun 23, 2020

Filter Results